Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine in Symptomatic Orthostatic Hypotension
NCT01518946Phase 4Completed
- Sponsor
- Takeda
- Start
- May 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of midodrine in orthostatic hypotension (OH), sponsored by Takeda. Started May 2012; status: completed.
02
Drugs
midodrine
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT01518946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518946.